然而，一位美国的专家警告此新研究发现 - 减少雌激素受体阴性（estrogen-receptor negative, ER-negative）乳癌风险的结果很可能纯属偶然。
基于1个网页-相关网页
Breast cancer can be broadly separated into hormone-responsive (ER-positive) and non-hormone-responsive (ER-negative) subtypes.
乳腺癌可以大致被分类为雌激素受体阳性与雌激素受体阴性两类。
In this model, higher clinical tumor stage and ER-negative status were associated with a statistically significantly greater risk for distant relapse or death.
在此模型中，更高的临床肿瘤分级及雌激素受体阴性与远处复发或死亡存在具有显著统计学差异的相关性。
Objective To study whether tamoxifen(TAM) can induce growth arrest and apoptosis of ER-negative MA782 mouse breast cancer cell line and to explore the molecular mechanisms.
目的探讨三苯氧胺（TAM）治疗乳腺癌分子作用机制及其与细胞周期的关系。
应用推荐